These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3223334)

  • 21. Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives.
    Serafetinides EA; Collins S; Clark ML
    J Nerv Ment Dis; 1972 Jan; 154(1):31-42. PubMed ID: 4550211
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuroleptic-induced skin pigmentation in chronic hospitalized schizophrenic patients.
    Ban TA; Guy W; Wilson WH
    Can J Psychiatry; 1985 Oct; 30(6):406-8. PubMed ID: 2866025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blue skin pigmentation and chlorpromazine.
    Haddad RI
    J Ky Med Assoc; 1977 Mar; 75(3):124-6. PubMed ID: 839129
    [No Abstract]   [Full Text] [Related]  

  • 24. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haloperidol versus chlorpromazine for treatment of schizophrenia.
    Leucht C; Kitzmantel M; Chua L; Kane J; Leucht S
    Schizophr Bull; 2008 Sep; 34(5):813-5. PubMed ID: 18658127
    [No Abstract]   [Full Text] [Related]  

  • 26. Antipsychotic drugs and plasma vasopressin in normals and acute schizophrenic patients.
    Raskind MA; Courtney N; Murburg MM; Backus FI; Bokan JA; Ries RK; Dorsa DM; Weitzman RE
    Biol Psychiatry; 1987 Apr; 22(4):453-62. PubMed ID: 3567260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum lipids and lipoproteins in schizophrenic patients receiving major tranquilizers.
    Shafique M; Khan IA; Akhtar MH; Hussain I
    J Pak Med Assoc; 1988 Oct; 38(10):259-61. PubMed ID: 3144603
    [No Abstract]   [Full Text] [Related]  

  • 28. A comparison of the relative efficacy of Serenace and chlorpromazine in the treatment of chronic schizophrenics.
    Rompel H; Segal H
    J Int Med Res; 1978; 6(2):126-32. PubMed ID: 344086
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Harris K; Lamy M; Sorter M; Frye C; Terhune L; Erickson CA; Ruschman G; Dominick KC
    J Child Adolesc Psychopharmacol; 2021 Sep; 31(7):516-517. PubMed ID: 34543080
    [No Abstract]   [Full Text] [Related]  

  • 30. Chlorpromazine therapy, and associated acute disturbances of cardiac rhythm.
    Aherwadkar SJ; Efendigil MC; Coulshed N
    Br Heart J; 1974 Dec; 36(12):1251-2. PubMed ID: 4441459
    [No Abstract]   [Full Text] [Related]  

  • 31. An electron microscopic study of chlorpromazine pigmentation.
    Hashimoto K; Wiener W; Albert J; Nelson RG
    J Invest Dermatol; 1966 Oct; 47(4):296-306. PubMed ID: 5954160
    [No Abstract]   [Full Text] [Related]  

  • 32. Rapid tranquilization of acutely psychotic patients with intramuscular haloperidol and chlorpromazine.
    Man PL; Chen CH
    Psychosomatics; 1973; 14(1):59-63. PubMed ID: 4605009
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of injectable haloperidol and chlorpromazine.
    Ritter RM; Davidson DE; Robinson TA
    Am J Psychiatry; 1972 Jul; 129(1):78-81. PubMed ID: 4556089
    [No Abstract]   [Full Text] [Related]  

  • 34. Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance.
    Singh MM
    Dis Nerv Syst; 1976 Apr; 37(4):191-6. PubMed ID: 767080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Updating haloperidol: 1975].
    Ayd FJ
    Acta Physiol Lat Am; 1978 Sep; 24(3):233-8. PubMed ID: 751446
    [No Abstract]   [Full Text] [Related]  

  • 36. Two cases of deep vein thrombosis associated with antipsychotic drug use.
    Matsumoto M; Konno T; Tamba K; Abe T; Kato S; Kajii E
    Psychiatry Clin Neurosci; 2004 Aug; 58(4):450-1. PubMed ID: 15298663
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on the pupillary reaction in the course of a psychotropic treatment].
    Popkowska N
    Neurol Neurochir Psychiatr Pol; 1966 Feb; 16(2):167-71. PubMed ID: 5913352
    [No Abstract]   [Full Text] [Related]  

  • 38. Cutaneous and ocular changes associated with the use of chlorpromazine.
    Wolf ME; Richer S; Berk MA; Mosnaim AD
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
    Conley RR; Tamminga CA; Bartko JJ; Richardson C; Peszke M; Lingle J; Hegerty J; Love R; Gounaris C; Zaremba S
    Am J Psychiatry; 1998 Jul; 155(7):914-20. PubMed ID: 9659857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular changes produced by chlorpromazine.
    Dencker SJ; Enoksson P
    Acta Ophthalmol (Copenh); 1966; 44(3):397-403. PubMed ID: 5953234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.